.Even with izokibep preserving its newfound winning touch in the clinic, Acelyrin is actually no lon...
.Rivus Pharmaceuticals has plumped up the leads of its fat-busting, muscle-sparing drug applicant, d...
.Ovid Rehab presently showed final month that it was actually trimming its headcount as the firm get...
.Eli Lilly has opened a $700 million R&D center in the Boston ma Seaport, boosting its RNA as wel...
.Merely five months after protecting a $one hundred million IPO, Vast Bio is already laying off some...
.The first stages of oncology R&D aren't except intriguing brand-new modalities, and also Halda R...
.Psychopharmacology has drawn three short articles concerning midstage medical trial data analyzing ...
.Avidity Biosciences pleased clients along with period 1/2 information in Duchenne muscular dystroph...
.Actinogen Medical's cortisol blocker has missed out on the major endpoint of a stage 2 research in ...
.Antibody-drug conjugates (ADCs) have been at the center of a lot of a billion-dollar biobuck licens...